XFOR - X4 Pharmaceuticals Inc

4.15
0.390   9.398%

Share volume: 590,387
Last Updated: 03-09-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$3.76
0.39
0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-07-2024 08-08-2024 11-13-2024 03-25-2025 05-01-2025 08-08-2025 11-05-2025
Total revenue 0.000 563.000 K 560.000 K 1.434 M 28.807 M 2.202 M 1.964 M
Cost of revenue 0.000 268.000 K 227.000 K 302.000 K 4.716 M 326.000 K 351.000 K
Gross profit 0.000 295.000 K 333.000 K 1.132 M 24.091 M 1.876 M 1.613 M
    inf% 12.88% 239.94% 2,028.18% -92.21% -14.02%  
Operating expenses 37.289 M 34.192 M 34.833 M 36.847 M 33.534 M 27.879 M 28.923 M
Selling general and admin 17.435 M 13.278 M 15.660 M 15.145 M 15.021 M 9.527 M 11.586 M
Research and development 19.854 M 20.914 M 19.173 M 21.702 M 18.513 M 18.352 M 17.337 M
Total expenses 37.289 M -70.808 M 34.833 M 36.847 M 33.534 M 27.879 M 28.923 M
    -289.89% 149.19% 5.78% -8.99% -16.86% 3.74%  
Operating income -37.289 M 71.103 M -34.500 M -35.715 M -9.443 M -26.232 M -27.509 M
Ebit -50.939 M 91.462 M -36.138 M -38.526 M 1.492 M -24.137 M -28.489 M
Pretax income -51.747 M 90.851 M -36.681 M -39.563 M 316.000 K -25.704 M -29.845 M
    -275.57% -140.37% 7.86% -100.80% -8,234.18% 16.11%  
Income tax 19.000 K 18.000 K 15.000 K 258.000 K 34.000 K 37.000 K -30.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -51.766 M 90.833 M -36.696 M -39.821 M 282.000 K -25.741 M -29.815 M
    275.47% -140.40% -8.52% 100.71% -9,228.01% -15.83%